Modulation of cellular radiation responses by histone deacetylase inhibitors

Oncogene

Volumn 25, Issue 28, 2006, Pages 3885-3893

  Karagiannis, T C ^a   El Osta, A ^b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Chromatin remodeling; HDAC inhibitor; Histone acetylation; Histone deacetylase; Radiation response; Radiosensitivity

Indexed keywords

4 N ACETYLDINALINE; ANGIOGENESIS INHIBITOR; APICIDIN; BUTYRIC ACID; DEPSIPEPTIDE; FLAVOPIRIDOL; FLUDARABINE; HISTONE DEACETYLASE INHIBITOR; IMATINIB; N (2 AMINOPHENYL) 4 (3 PYRIDINYLMETHOXYCARBONYLAMINOMETHYL)BENZAMIDE; PROTEASOME INHIBITOR; RETINOIC ACID; TRICHOSTATIN A; VALPROIC ACID; VORINOSTAT;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL CULTURE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; SOLID TUMOR; ULTRAVIOLET RADIATION;

ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; RADIATION TOLERANCE;

EID: 33646562250     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209417     Document Type: Review

References (121)

1. Abraham RT. (2001). Genes Dev 15: 2177-2196.
2. Alland L, Muhle R, Hou Jr H, Potes J, Chin L, Schreiber-Agus N et al. (1997). Nature 387: 49-55.
3. Arundel CM, Glicksman AS, Leith JT. (1985). Radiat Res 104: 443-448.
4. Arundel CM, Leith JT. (1987). Int J Radiat Oncol Biol Phys 13: 593-601.
5. Biade S, Stobbe CC, Boyd JT, Chapman JD. (2001). Int J Radiat Biol 77: 1033-1042.
6. Blaheta RA, Michaelis M, Driever PH, Cinatl Jr J. (2005). Med Res Rev 25: 383-397.
7. Boivin AJ, Momparler LF, Hurtubise A, Momparler RL. (2002). Anticancer Drugs 13: 869-874.
8. Bowden CL, Singh V. (2005). Acta Psychiatr Scand Suppl 426: 13-20.
9. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY et al. (1996). Cell 84: 843-851.
10. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA et al. (2002). Proc Natl Acad Sci USA 99: 11700-11705.
11. Camphausen K, Burgan W, Cerra M, Oswald KA, Trepel JB, Lee MJ et al. (2004a). Cancer Res 64: 316-321.
12. Camphausen K, Cerna D, Scott T, Sproull M, Burgan WE, Cerra MA et al. (2005). Int J Cancer 114: 380-386.
13. Camphausen K, Scott T, Sproull M, Tofilon PJ. (2004b). Clin Cancer Res 10: 6066-6071.
14. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, Staudt DW, Lee A et al. (2003). Nat Cell Biol 5: 675-679.
15. Chang SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS et al. (1999). J Clin Oncol 17: 984-990.
16. Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM. (2005). Int J Radiat Oncol Biol Phys 62: 223-229.
17. Chiu CY, Cary RB, Chen DJ, Peterson SR, Stewart PL. (1998). J Mol Biol 284: 1075-1081.
18. Chung YL, Lee YH, Yen SH, Chi KH. (2000). Clin Cancer Res 6: 1452-1458.
19. Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, Schreiber SL et al. (1998). EMBO J 17: 159-169.
20. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. (2003). Biochem J 370: 737-749.
21. de Vries E, van Driel W, Bergsma WG, Arnberg AC, van der Vliet PC. (1989). J Mol Biol 208: 65-78.
22. Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A. (2004). Amino Acids 26: 435-441.
23. Dokmanovic M, Marks PA. (2005). J Cell Biochem 96: 293-304.
24. Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC. (2005). Annu Rev Pharmacol Toxicol 45: 495-528.
25. Durocher D, Jackson SP. (2001). Curr Opin Cell Biol 13: 225-231.
26. Falzon M, Fewell JW, Kuff EL. (1993). J Biol Chem 268: 10546-10552.
27. Ferguson DO, Alt FW. (2001). Oncogene 20: 5572-5579.
28. Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA et al. (1999). Nature 401: 188-193.
29. Fischle W, Wang Y, Allis CD. (2003). Nature 425: 475-479.
30. Frey RR, Wada CK, Garland RB, Curtin ML, Michaelides MR, Li J et al. (2002). Bioorg Med Chem Lett 12: 3443-3447.
31. Furumai R, Komatsu Y, Nishino N, Khochbin S, Yoshida M, Horinouchi S. (2001). Proc Natl Acad Sci USA 98: 87-92.
32. Furumai R, Matsuyama A, Kobashi N, Lee KH, Nishiyama M, Nakajima H et al. (2002). Cancer Res 62: 4916-4921.
33. Gregoretti IV, Lee YM, Goodson HV. (2004). J Mol Biol 338: 17-31.
34. Gregory PD, Wagner K, Horz W. (2001). Exp Cell Res 265: 195-202.
35. Grozinger CM, Schreiber SL. (2002). Chem Biol 9: 3-16.
36. Grunstein M. (1997). Nature 389: 349-352.
37. Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS. (2004). Cancer Res 64: 1079-1086.
38. Hammarsten O, Chu G. (1998). Proc Natl Acad Sci USA 95: 525-530.
39. Hess-Stumpp H. (2005). Eur J Cell Biol 84: 109-121.
40. Jackson SP. (2001). Biochem Soc Trans 29: 655-661.
41. Jackson SP. (2002). Carcinogenesis 23: 687-696.
42. Jeggo P, O'Neill P. (2002). DNA Repair (Amsterdam) 1: 771-777.
43. Jenuwein T, Allis CD. (2001). Science 293: 1074-1080.
44. Johnstone RW. (2002). Nat Rev Drug Discov 1: 287-299.
45. Johnstone RW, Licht JD. (2003). Cancer Cell 4: 13-18.
46. Ju R, Muller MT. (2003). Cancer Res 63: 2891-2897.
47. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS et al. (2000). J Biol Chem 275: 20436-20443.
48. Jung M. (2001). Curr Med Chem 8: 1505-1511.
49. Jung M, Velena A, Chen B, Petukhov PA, Kozikowski AP, Dritschilo A. (2005). Radiat Res 163: 488-493.
50. Kao GD, McKenna WG, Guenther MG, Muschel RJ, Lazar MA, Yen TJ. (2003). J Cell Biol 160: 1017-1027.
51. Karagiannis TC, Kn H, El-Osta A. (2005). Cancer Biol Ther 4: 787-793.
52. Kastan MB, Lim DS, Kim ST, Xu B, Canman C. (2000). Cold Spring Harb Symp Quant Biol 65: 521-526.
53. Kelly WK, Marks PA. (2005). Nat Clin Pract Oncol 2: 150-157.
54. Kelly WK, O'Connor OA, Krug LM, Chiao JH, Heaney M, Curley T et al. (2005). J Clin Oncol 23: 3923-3931.
55. Kelly WK, O'Connor OA, Marks PA. (2002). Expert Opin Investig Drugs 11: 1695-1713.
56. Kelly WK, Richon VM, O'Connor O, Curley T, MacGregor-Curtelli B, Tong W et al. (2003). Clin Cancer Res 9: 3578-3588.
57. Khanna KK. (2000). J Natl Cancer Inst 92: 795-802.
58. Khanna KK, Jackson SP. (2001). Nat Genet 27: 247-254.
59. Khochbin S, Verdel A, Lemercier C, Seigneurin-Berny D. (2001). Curr Opin Genet Dev 11: 162-166.
60. Kim GD, Choi YH, Dimtchev A, Jeong SJ, Dritschilo A, Jung M. (1999). J Biol Chem 274: 31127-31130.
61. Kim JH, Shin JH, Kim IH. (2004). Int J Radiat Oncol Biol Phys 59: 1174-1180.
62. Kim MS, Baek JH, Chakravarty D, Sidransky D, Carrier F. (2005). Exp Cell Res 306: 94-102.
63. Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F. (2003). Cancer Res 63: 7291-7300.
64. Kim MS, Kwon HJ, Lee YM, Baek JH, Jang JE, Lee SW et al. (2001). Nat Med 7: 437-443.
65. Kim ST, Lim DS, Canman CE, Kastan MB. (1999). J Biol Chem 274: 37538-37543.
66. Kouzarides T. (1999). Curr Opin Genet Dev 9: 40-48.
67. Kouzarides T. (2000). EMBO J 19: 1176-1179.
68. Kruh J. (1982). Mol Cell Biochem 42: 65-82.
69. Lagger G, O'Carroll D, Rembold M, Khier H, Tischler J, Weitzer G et al. (2002). EMBO J 21: 2672-2681.
70. Lee SE, Moore JK, Holmes A, Umezu K, Kolodner RD, Haber JE. (1998). Cell 94: 399-409.
71. Leith JT. (1988). Radiat Res 114: 186-191.
72. Lieber MR, Ma Y, Pannicke U, Schwarz K. (2003). Nat Rev Mol Cell Biol 4: 712-720.
73. Loscher W. (1999). Prog Neurobiol 58: 31-59.
74. Louis M, Rosato RR, Battaglia E, Neguesque A, Lapotre A, Grant S et al. (2005). Int J Oncol 26: 1569-1574.
75. Luo J, Su F, Chen D, Shiloh A, Gu W. (2000). Nature 408: 377-381.
76. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. (2001). Nat Rev Cancer 1: 194-202.
77. Marks PA, Jiang X. (2005). Cell Cycle 4: 549-551.
78. Marks PA, Richon VM, Miller T, Kelly WK. (2004). Adv Cancer Res 91: 137-168.
79. Marks PA, Richon VM, Rifkind RA. (2000). J Natl Cancer Inst 92: 1210-1216.
80. Miller AA, Kurschel E, Osieka R, Schmidt CG. (1987). Eur J Cancer Clin Oncol 23: 1283-1287.
81. Mimori T, Hardin JA. (1986). J Biol Chem 261: 10375-10379.
82. Mitsiades CS, Mitsiades NS, McMullan CJ, Poulaki V, Shringarpure R, Hideshima T et al. (2004). Proc Natl Acad Sci USA 101: 540-545.
83. Munshi A, Kurland JF, Nishikawa T, Tanaka T, Hobbs ML, Tucker SL et al. (2005). Clin Cancer Res 11: 4912-4922.
84. Nakano K, Vousden KH. (2001). Mol Cell 7: 683-694.
85. Nome RV, Bratland A, Harman G, Fodstad O, Andersson Y, Ree AH. (2005). Mol Cancer Ther 4: 1231-1238.
86. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. (2000). Science 288: 1053-1058.
87. Olive PL, Banath JP. (2004). Int J Radiat Oncol Biol Phys 58: 331-335.
88. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. (2000). Curr Biol 10: 886-895.
89. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE et al. (1993). N Engl J Med 328: 81-86.
90. Perucca E. (2002). CNS Drugs 16: 695-714.
91. Petrij F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RC, Masuno M et al. (1995). Nature 376: 348-351.
92. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. (2001). J Biol Chem 276: 36734-36741.
93. Piekarz R, Bates S. (2004). Curr Pharm Des 10: 2289-2298.
94. Piekarz RL, Robey RW, Zhan Z, Kayastha G, Sayah A, Abdeldaim AH et al. (2004). Blood 103: 4636-4643.
95. Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L et al. (2001). Invest New Drugs 19: 1-11.
96. Rich T, Allen RL, Wyllie AH. (2000). Nature 407: 777-783.
97. Richardson C, Jasin M. (2000). Nature 405: 697-700.
98. Richon VM, Emiliani S, Verdin E, Webb Y, Breslow R, Rifkind RA et al. (1998). Proc Natl Acad Sci USA 95: 3003-3007.
99. Rogakou EP, Boon C, Redon C, Bonner WM. (1999). J Cell Biol 146: 905-916.
100. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. (1998). J Biol Chem 273: 5858-5868.
101. Rooney S, Alt FW, Lombard D, Whitlow S, Eckersdorff M, Fleming J et al. (2003). J Exp Med 197: 553-565.
102. Rotman G, Shiloh Y. (1999). Oncogene 18: 6135-6144.
103. Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T et al. (1999). Proc Natl Acad Sci USA 96: 4592-4597.
104. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). Genes Dev 12: 2831-2841.
105. Singh SB, Zink DL, Liesch JM, Mosley RT, Dombrowski AW, Bills GF et al. (2002). J Org Chem 67: 815-825.
106. Snead III OC, Miles MV. (1985). J Pediatr 106: 323-325.
107. Spotswood HT, Turner BM. (2002). J Clin Invest 110: 577-582.
108. Struhl K. (1998). Genes Dev 12: 599-606.
109. Tabe Y, Konopleva M, Contractor R, Munsell M, Schober WD, Jin L et al. (2005). Blood [DOI 10.1182/blood-2004-10-4126].
110. Taddei A, Roche D, Bickmore WA, Almouzni G. (2005). EMBO Rep 6: 520-524.
111. Teo SH, Jackson SP. (1997). EMBO J 16: 4788-4795.
112. Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF. (2003). Ann NY Acad Sci 983: 84-100.
113. Turner BM. (2002). Cell 111: 285-291.
114. West RB, Yaneva M, Lieber MR. (1998). Mol Cell Biol 18: 5908-5920.
115. Wilson TE, Grawunder U, Lieber MR. (1997). Nature 388: 495-498.
116. Yoshida M, Kijima M, Akita M, Beppu T. (1990). J Biol Chem 265: 17174-17179.
117. Yoshida M, Matsuyama A, Komatsu Y, Nishino N. (2003). Curr Med Chem 10: 2351-2358.
118. Zgheib O, Huyen Y, DiTullio Jr RA, Snyder A, Venere M, Stavridi ES et al. (2005). Radiother Oncol 76: 119-122.
119. Zhang Y, Adachi M, Zhao X, Kawamura R, Imai K. (2004a). Int J Cancer 110: 301-308.
120. Zhang Y, Jung M, Dritschilo A, Jung M. (2004b). Radiat Res 161: 667-674.
121. Zhang Y, Reinberg D. (2001). Genes Dev 15: 2343-2360.